Summary of Product Characteristics
last updated on the eMC:
11/02/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 11/02/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 1 -Name of the Medicinal product
|
| Date of revision of text on the SPC: 02-Feb-2010 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to section 1 of SPC Name of Medicinal Product to Trandate 5mg/ml solution for injection
|
|
Updated on 22/09/2005 and displayed until 11/02/2010
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 12/02/2003 and displayed until 22/09/2005
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
|
|
Updated on 02/07/2001 and displayed until 12/02/2003
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 06/09/1999 and displayed until 02/07/2001
|
Reasons for adding or updating:
|
|
|
|